Turnover of leading European pharmaceutical markets 2018
Germany was the leading pharmaceutical market in Europe with a turnover of over 41.5 billion euros in 2018. France and Italy followed with turnovers of 28.5 billion and 26.8 billion euros respectively. The top five were rounded off by Great Britain and Spain, showing the five largest countries in the EU, otherwise known at the EU-5, had the markets with the greatest turnovers in Europe by a large margin.
German pharmaceutical market
When the turnover of the German pharmaceutical market is broken down, it is prescription drugs that account for the majority of the turnover. Prescription medication accounted for approximately 27.9 billion euros of turnover, followed by pharmacy drugs at 3.16 billion euros.
German pharmaceutical exports
Over a fifteen-year period the value of pharmaceutical exports from Germany has skyrocketed. Increasing from approximately 18.8 billion euros in 2000 to over 83 billion euros in 2018. The leading destination for these exports is the United States with an export value of almost 14 billion euros, followed by the Netherlands with an export value of 9.3 billion euros
German pharmaceutical market
When the turnover of the German pharmaceutical market is broken down, it is prescription drugs that account for the majority of the turnover. Prescription medication accounted for approximately 27.9 billion euros of turnover, followed by pharmacy drugs at 3.16 billion euros.
German pharmaceutical exports
Over a fifteen-year period the value of pharmaceutical exports from Germany has skyrocketed. Increasing from approximately 18.8 billion euros in 2000 to over 83 billion euros in 2018. The leading destination for these exports is the United States with an export value of almost 14 billion euros, followed by the Netherlands with an export value of 9.3 billion euros
